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Abstract: A bio-degradable scaffold incorporating osteoinduc-
tive factors is one of the alternative methods for achieving the
regeneration of a mandibular bone defect. The current pilot
study addressed such a bone reconstruction in a non-human
primate model, Macaca fascicularis monkeys, with an engi-
neered poly(E-caprolactone) (PCL) scaffold, provided with a
carbonate-substituted hydroxyapatite coating. The scaffolds
were implanted into unilaterally created mandibular segmen-
tal defects in 24 monkeys. Three experimental groups were
formed: (1) scaffolds with rhBMP-2 (n 5 8), (2) scaffolds with
autologous mixed bone marrow cells (n 5 8), and (3) empty
scaffolds as a control group (n 5 8). Evaluation was based on
clinical observation as well as micro-CT, mechanical, and his-
tological analyses. Despite a high infection rate, the overall
results showed that the currently designed PCL scaffolds had
insufficient load-bearing capability, and complete bone union
was not achieved after 6 months of implantation. Neverthe-
less, the group of PCL scaffolds loaded with rhBMP-2 showed
evidence of bone-regenerative potential, in contrast to PCL
with autologous mixed bone marrow cells and the control
group. VC 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl
Biomater, 102B: 962–976, 2014.
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INTRODUCTION
Mandibular bone provides the skeletal base for teeth, which
play a critical role in mastication, speech, and maintenance
of the facial proﬁle.1 Reconstruction of large mandibular
defects caused by trauma, tumor resection, and congenital
defects is a signiﬁcant clinical challenge.2 Various methods
of mandibular defect reconstruction have been reported in
several surgical techniques involving reconstruction plate,
free bone graft, pedicle bone graft, particulate bone cancel-
lous marrow graft, microvascular free ﬂap, transport dis-
traction osteogenesis, modular endoprosthesis, and tissue
engineering. Each technique has its own beneﬁts and limita-
tions. The current “gold standard” treatment is either an
autogenous free bone graft or a vascularized microvascular
free ﬁbular ﬂap.1 However, even this standard has limita-
tions in terms of aesthetic and functional outcomes when the
bone graft does not replicate the original complex mandibular
geometry. The procedure is also time-consuming, including a
hospital stay, and is associated with signiﬁcant donor-site
morbidity. These problems have led clinicians to explore
alternative procedures for mandibular reconstruction.
In 2006, Lee et al.3 introduced a modular endoprosthe-
sis for mandibular reconstruction. This device was made of
titanium alloy, and the prosthesis stems were cemented into
the remaining bone stumps on either side of the mandibular
defect. The experimental animal study with this approach
showed an abundance of bone formation around the body
of the modular endoprosthesis at 6 months post-surgery;
however, the soft-tissue healing was not ideal, resulting in
dehiscence and, in some cases, hardware exposure. In
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addition, hardware failure (i.e., several screws of the modu-
lar endoprosthesis becoming loose) was found.3–5
A recently introduced alternative direction for mandibu-
lar bone reconstruction involves tissue-engineering techni-
ques, which offer potential advantages such as the absence
of donor-site morbidity and an ability to regenerate original
bone geometry. Based on the results of the earlier study
with the titanium modular endoprosthesis, we decided to
pursue such a tissue-engineering approach and designed a
biodegradable osteoinductive modular endoprosthetic scaf-
fold for the regeneration of a segmental mandibular defect.
Poly(E-caprolactone) (PCL) was selected for the manu-
facture of the endoprosthesis. PCL is a bioresorbable poly-
mer with potential applications for bone and cartilage
repair and has several advantages over other polymers. PCL
is more stable in ambient conditions, is readily available in
large quantities, and can be easily combined as well as proc-
essed with other materials to further formulate the tissue
response.6,7 PCL scaffolds can be fabricated by selective
laser sintering (SLS), a rapid prototyping/solid free-form
fabrication (SFF) technique to ﬁt complex anatomic loca-
tions. This technology allows for the design of a scaffold
with computationally predicted properties and a possible
global anatomic architecture that matches the original bone
defect and supports the in-growth of bone tissue.8,9 The
selected percentages of scaffold porosity, structure, and
mechanical design can be controlled. Porosity between 37
and 55% has been reported to possess mechanical proper-
ties comparable with those of human trabecular bone, and
the compressive modulus of such a scaffold was found to be
within the 52–68-MPa range, with ultimate compressive
strength within the 2.0–3.2-MPa range.9 This makes such a
manufactured material an attractive substitute for human
bone and enhances its application for bone regeneration.
Osteoinductive or autoinductive bone formation is a
mechanism of cellular differentiation towards bone of one
tissue due to the physicochemical effect or contact with
another tissue.10 It generally can only be induced by hetero-
topic implantation of demineralized bone matrix (DBM) or
BMPs into a region where bone does not naturally grow.11
PCL is not osteoinductive, which limits its applications in
the regeneration of critical-sized bone defects. To enhance
the bone-regenerative properties, PCL scaffolds containing
growth factors, and in conjunction with a carbonate-
substituted hydroxyapatite coating, have been shown to be
promising in creating osteoinductive scaffolds. In 2011,
Suarez-Gonzalez et al. reported mineral coatings on polycap-
rolactone scaffolds serving as templates for growth-factor
binding and release.12 Mineral coatings were formed by a
biomimetic approach that consisted of the incubation of
scaffolds in modiﬁed simulated body ﬂuids (mSBF) with a
composition similar to that of human plasma, but with dou-
ble the concentrations of calcium and phosphate. Such scaf-
folds demonstrated the ability of attachment and sustained
release of growth factors, such as VEGF and BMP-2, which
were dependent on the solubility of the mineral coating.12,13
In addition to growth factors such as rhBMP-214–18 and
rhBMP-7,14,19–21 bone marrow stromal cells (BMSCs) have
been found to be a stimulus for bone regeneration, being
capable of differentiation into mesenchymal tissues such as
bone and cartilage.22–26 BMSCs or cultivated osteoprogeni-
tor cells can be seeded into a porous scaffold, and, when
given the appropriate environmental signals, can be directed
down the osteogenic lineage and cued to form bone tis-
sue.27 BMSCs are readily available and can be isolated from
bone marrow or fat tissue. Numerous successful animal
studies have been reported, where mandibular continuity
defects were regenerated on a scaffold provided with bone
marrow stromal cells.26,28–30
In view of the above, the aim of this study was to regen-
erate a segmental mandibular bone defect by means of a 3D
designed PCL scaffold provided with a carbonate-
substituted hydroxyapatite (CHA) coating for the delivery of
osteoinductive factors to the defect site. The study com-
pared the use of empty PCL scaffolds (PCL-control), PCL
scaffolds seeded with autologous bone marrow cells in a
bovine collagen type I gel (PCL-CELL), and PCL scaffolds
provided with additional rhBMP-2 (PCL-BMP). We hypothe-
sized that the osteoinductive scaffold loaded with rhBMP-2
or bone marrow cells could achieve bone union and overly-
ing soft-tissue healing with sufﬁcient load-bearing capacity
within 6 months after its installation into the mandibular
segmental defect in a non-human primate model.
MATERIALS AND METHODS
Animals
Twenty-four healthy, adult male Macaca fascicularis mon-
keys, with an average weight of 6–7 kg, were used in this
study. The experimental protocol was approved by the Insti-
tutional Animal Care and Use Committee of SingHealth in
Singapore. Animal surgery was performed at the SingHealth
Experimental Animal Centre (SEMC), Singapore. The animal
laboratory has been certiﬁed by the International Associa-
tion for the Assessment of Laboratory Animal Care (IACUC),
Singapore.
PCL scaffolds and calcium phosphate coating
Poly-E-caprolactone (PCL) powder (CAPA 6501, Solvay Cap-
rolactones, Warrington, Cheshire, UK) was used to fabricate
the PCL scaffolds. This particular form of PCL has a melting
point of 60C, a molecular weight of 50,000 kDa, and parti-
cle size distribution in the 10–100-lm range.
Fabrication of PCL scaffolds. The PCL scaffolds were fabri-
cated by the Department of Biomedical Engineering, Univer-
sity of Michigan, Ann Arbor. For the fabrication process,
computed tomographic (CT) scans of dry monkey mandibles
were made, and scaffolds were fabricated via laser sintering
as previously reported.9 With the CT images as a guide,
mandibular scaffolds were created with a controlled archi-
tecture. The design was then exported to a Sinterstation
2000TM machine (3D Systems, Valencia, CA) in STL ﬁle for-
mat and used to construct scaffolds layer-by-layer, with a
powder layer, by the selective laser sintering (SLS) process-
ing. The body of the implant was 15-mm long and 12-mm
high and possessed a 3D orthogonal periodic porous
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architecture. The body of the implant was also modular,
comprised of anterior and posterior components, which
were ﬁxed together with a special lock-on design. Mechani-
cal analysis conﬁrmed that the “dovetail joint” between the
two components was failing (fracture point) at 30 N. The
stems were 12-mm long, 4-mm high, and 2.5 mm in diame-
ter and were made to ﬁt the marrow space of the mandible
as closely as possible. In cross-section, the stems showed a
star-shaped appearance, to increase the bone-scaffold con-
tact area. Micro-CT analysis reviewed that the PCL scaffolds
had a reasonably homogenous structure, with total surface
area of 2089 mm2, porosity 75%, and pore size of 1200 lm.
All pores are interconnected (Figure 1).
PCL scaffolds with CHA coating. The PCL scaffolds were
used as-received or provided with a CHA coating. The scaf-
fold components were incubated in a modiﬁed simulated
body ﬂuid (mSBF) for 8 days at 37C under continuous
rotation. Prior to mSBF incubation, the PCL components
were hydrolyzed in 1 M NaOH for 60 min. After hydrolysis,
plates were rinsed and incubated in the mSBF. The mSBF
solution had a composition similar to that of human plasma,
but with double the concentrations of calcium and phos-
phate to enhance mineral growth, and was prepared as pre-
viously reported9,13: brieﬂy, 141 mM NaCl, 4.0 mM KCl, 0.5
mM MgSO4, 1.0 mM MgCl2, 4.2 mM NaHCO3, 5.0 mM CaCl2,
and 2.0 mM KH2PO4 in deionized ultra-ﬁltered water, with
pH adjusted to 6.8 with 2 N HCl or 2 N NaOH. Before use in
the animal study, all scaffolds (non-coated and CHA-coated)
were sterilized by ethylene oxide gas.
Bone morphogenic protein
Recombinant human Bone Morphogenic Protein-2 (rhBMP-
2) in white freeze-dried powder form (GenScript, Piscat-
away, NJ) was used. RhBMP-2 solution was prepared
according to the manufacturer’s instructions, that is, 0.75
mL of 20 mmol of acetic acid was gently dripped directly
onto 1 mg rh-BMP2, and 0.75 mL of sterile 13 PBS was
added. Then, this solution was gently dripped onto and
absorbed by the PCL scaffolds. Subsequently, scaffolds were
incubated in a continuously shaking machine at 250 rpm.
The scaffolds were turned over at 7.5 min, and shaking con-
tinued for an additional 7.5 min. This preparation was per-
formed under sterile conditions in the operating room,
while the mandibular segmental operation was performed
in each individual monkey.
Preparation of monkey autologous bone marrow cells in
collagen gel
After the monkeys were anesthetized, a 3-mL quantity of
bone marrow was aspirated from the trochanter bone from
each monkey. The aspirate was processed with red blood
cell lysis and cell counting under sterile conditions.
Ultrapure Bovine Collagen Solution (Sigma–AldrichV
R
-
C4243, St. Louis, MO) was used as a carrier for bone mar-
row cell-seeding. Collagen gel was prepared by the pipetting
of 0.8 mL of 3 mg/mL Ultrapure Bovine Collagen Solution
into an Eppendorf tube. Subsequently, 0.1 mL of 103 PBS
was added to the solution, followed by gentle mixing with
75 lL 0.1 M NaOH. The pH of the solution was kept in the
range of pH 7–8. Then, a 125-lL quantity of bone marrow
cells (equivalent to 5 3 106 cells) was mixed with 475 lL
(pH-adjusted for appropriate gelling conditions) collagen
solution. Bone marrow cells in collagen gel were incubated
at 37C, in a humidiﬁed atmosphere of 95% O2 and 5%
CO2, for 40–45 min.
Analysis of preliminary data from a pilot study con-
ﬁrmed that the collagen solution evoked no inﬂammatory
or allergic reaction in the monkeys and proved that the via-
bility of the marrow cells was maintained in the prepared
collagen gel (data not shown).
Autologous bone marrow cells in 0.6 mL of collagen gel
were transferred into the porous PCL scaffold and placed in
an incubator. After 15 min, the outer surface of the cell-
seeded scaffold was coated with an additional 0.4 mL of col-
lagen gel. The construct was re-incubated for another 30
min before placement into the mandibular defect site.
Surgical procedure
The monkeys were fasted overnight and received 0.05 mg/
kg of intravenous atropine and 10 mg/kg of Ketamine (Par-
nell Laboratories, Alexandria, Australia) pre-operatively. All
FIGURE 1. PCL polymer endoprosthetic mandibular scaffold has anterior and posterior parts with a “dovetail” inter-lock design. A scaffold pin is
used to stabilize the two parts. Anterior and posterior endoprosthetic stems are designed to fit into the prepared cavity in the cancellous bone
of native mandibular segments. The surface of scaffold is coated with CHA. [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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animals were weighed prior to surgery. Induction and main-
tenance of anesthesia were performed with 2% isoﬂurane.
Endotracheal intubation was performed with oral endotra-
cheal tubes (gauge, 3.5 mm). Intravenous analgesic 2 mg/kg
carprofen (RimadlyV
R
) (Pﬁzer, NY) and antibiotics (ampicil-
lin/cloxacillin) 6–8 mg/kg were administered. The surgical
site was disinfected with 1% Cetrimide, followed by 0.05%
chlorhexidine and povidone iodine, and sterile drapes were
used. An incision was made intra-orally, beginning with two
vertical incisions between the second bicuspid and the ﬁrst
molar as well as behind the second molar. A horizontal inci-
sion 2–3 mm below the attached gingiva was made to con-
nect the two vertical incisions. The periosteum was
reﬂected to expose the lower border of the mandible at the
ostectomy sites. A tapered ﬁssure bur was used to perform
the resection, and the block was subsequently removed. A
15-mm section of the segmental defect was taken from the
right side of the mandible. Bleeding from the inferior alveo-
lar artery and vein was easily controlled with diathermy
when necessary.
Three experimental groups were created: (1) PCL scaf-
fold with CHA surface coating and soaked with rhBMP-2
(PCL-BMP, n 5 8); (2) PCL scaffold with CHA surface coat-
ing and seeded with bone marrow cells (PCL-CELL, n 5 8);
and (3) PCL scaffold with CHA surface coating, as a control
group (PCL-control, n 5 8). Before installation of the scaf-
folds, the medullar space of the anterior and posterior bone
stumps was prepared with a tapered drill (2.3 mm in diam-
eter) to a depth of 12 mm, to conform to the dimensions of
the stems of the PCL scaffolds. The stems of the anterior
and posterior modules were then inserted into the prepared
grooves and press-ﬁtted, and the stability was checked. The
anterior and posterior modules were then connected and
stabilized with a vertical pin (Figure 2).
After insertion of the endoprosthesis, occlusion was
evaluated. As intermaxillary ﬁxation was not possible in this
animal model, two Ti mini-plates with 5-mm Ti screws
were ﬁxed between mandibular stumps to immobilize the
reconstruction site. The buccinator and mylohyoid muscles
were dissected, mobilized, and sutured over the device by
means of 4/0 VicrylV
R
(Ethicon, Somerville, NJ), followed by
closure of the mucosa, thus creating a two-layer closure.
After surgery, radiographs were taken with a Siemens Poly-
mobil Plus machine set at 40 kV for 2 ms at a distance of
70 cm. During imaging, animals were positioned with their
right mandibles adjacent to the plate.
The animals were maintained in individual cages. Soft
diet was provided until sacriﬁce. Ampicillin/cloxacillin 6–8
mg/kg IM was administered for 7 days post-surgery, and
Ketorolac trometamol (Toradol) 15–30 mg/kg IM was given
for 2–3 days post-surgery.
Endoprosthesis retrieval
All animals were weighed and sacriﬁced at 6 months post-
operatively. Mandibular specimens from condyle to condyle,
with the device in situ, were harvested. Surrounding soft tis-
sue was removed except around the reconstructed site.
Radiographic examination was performed at the same set-
tings as used for the preliminary assessment.
In half of the animals of each group, mandibles were
harvested fresh to be used for mechanical testing. A 3-mL
quantity of pentobarbitone was injected into the cardiac
chamber to euthanize the animals. All retrieved specimens
were kept frozen at 220C until needed for analysis.
For the other half of the animals in each group, harvest-
ing was done after perfusion ﬁxation. A 16-gauge intrave-
nous catheter was inserted into the left ventricle and used
for circulation with 300–500 mL of Hartman’s solution, fol-
lowed by 750 mL of a mixture of 2.5% paraformaldehyde
and 2% glutaraldehyde. The specimens were kept soaked in
10% glutaraldehyde.
Micro-CT evaluation
The specimens containing the reconstruction device were
scanned in a GE eXplore Locus SP MicroCT scanner (GE
Healthcare, Thermo Scientiﬁc, Waltham, MA), with a focal
spot of 8 lm, pixel size of 18 lm, scanning conﬁguration
isotropic voxels of 8 3 8 3 8 lm3 focal spot size, and iso-
tropic resolutions at 8 lm.
Mini-plates and screws were removed before the scan-
ning process, to avoid scattering due to the presence of
metal. The area of scan was extended to the maximum
diameter of the scan view and beyond the region of interest
(ROI) and the reconstruction site, which included end-
points of the anterior and posterior scaffold stems. The digi-
tized signals were then transferred to a computer for
FIGURE 2. Clinical images of segmental mandibular reconstruction with PCL Endoprosthesis. The mandibular segment is stabilized by two tita-
nium mini-plates and -screws. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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reconstruction of the micro-CT slices. Standardized calibra-
tion was used for comparison with bone, air, and water. All
images were calibrated in Hounsﬁeld units (HU) for quanti-
tative analysis. The new bone analysis was analyzed with
MicroViewV
R
2.2 software (GE Healthcare, Waukesha, WI)
and MimicsV
R
Software (Mimics 14.01 64-bit, Materialise,
Leuven, Belgium).
Micro-CT slices were reconstructed perpendicular to the
long axis of the mandibular reconstruction. Bone union of
the mandibular stem was evaluated. Bone volume (%) at
the reconstruction site was identiﬁed with Microview com-
puter software. To investigate new bone formation inside
the scaffold, we used the Stereo Lithography (STL) digital
data of the scaffold to indicate the ROI as the boundary of
the scaffold body, with MimicsV
R
Software. The created ROI
was transferred to the individual scan of the specimen in
the MicroViewV
R
program. Bone volume (%), tissue mineral
density (TMD) value (mg/mL), and bone mineral density
(BMD) (mg/mL) were then evaluated (Figure 3).
Mechanical testing examination
The specimens for mechanical testing were processed at the
Biomedical Engineering Laboratory, College of Engineering,
The University of Michigan, Ann Arbor, MI. The three-point
bending test was used to determine their stiffness in an
MTS Alliance RT/30 EliteTM Controller testing machine (Tes-
tResources, Shakopee, MN). Each specimen was placed on
the biomechanical three-point bending test ﬁxture, with
both condyles and the mid-anterior lingual bone surface
placed on a custom-made jig (Figure 4). A force at a con-
stant displacement rate of 25 mm/min was applied to the
lower border of the mandibular body. The load–displace-
ment data were recorded at a frequency of 15 Hz, for deter-
mination of the stiffness of the reconstructed mandibles
without breaking the specimens.
A pilot study was conducted to determine the maximum
load that could be applied without mandibular fracture. The
data were acquired from two dry intact macaque mandibles.
The ﬁrst dry mandible was placed on the biomechanical
three-point bending testing ﬁxture as above. The vertical
linear displacement was applied by vertical load on one
side of the mandibular body. Once the pre-load was reached,
data were acquired at a rate of 15 Hz, while a load was
applied at a displacement rate of 0.25 mm/min until the
failure load resulted in mandibular fracture at a loading
force of 889.6 N. The second dry mandibular specimen was
tested similarly, except that the maximum load was reduced
to 111.21 N, or 12.5% of the failure load, to avoid mandibu-
lar fracture. The stiffness of the mandibular specimen was
found to be 420 N/mm and 643.7 N/mm on the contralat-
eral side without fracture.
Before mechanical analysis, the harvested specimens
were thawed to room temperature from 220C for 2 h. All
specimens were maintained in moist conditions until the
test was completed. Before mechanical testing, mini-plates
and screws were removed, including most of the soft tissue
around the mandible. Bilateral mandibular coronoid proc-
esses and canine cusps were trimmed to prevent interfer-
ence with the ﬁxation jig during mechanical testing. Into the
FIGURE 3. The ROI inside the scaffold was created along the boundary of the scaffold body with the Mimics x64 14.0 computer program. The
quantity of newly regenerated bone inside the body of the scaffold was analyzed with MicroViewTM 2.2 GE Healthcare computer software. [Color
figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 4. Each of the mandibles was placed on the three-point bend-
ing jig for biomechanical testing with the Alliance RT/30 EliteTM Con-
troller. The jig model was designed by the Department of Biomedical
Engineering, University of Michigan, Ann Arbor. The mechanical test-
ing system was exposed to compression loads that simulated masti-
catory loads on each side of the mandible (reconstructed and non-
reconstructed sides). Vertical linear displacement was applied by the
Alliance RT/30 EliteTM Controller machine. [Color figure can be viewed
in the online issue, which is available at wileyonlinelibrary.com.]
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anterior lingual bone of each mandible, a 3-mm hemisphere
was drilled by means of a surgical round bur to prevent dis-
placement of the specimen during force application.
Mechanical testing was done for both sides of the mandible
at a displacement rate of 0.25 mm/min until 111.201 N was
reached. The maximum applied moment (MAM) or maxi-
mum moment at failure (MMF) point due to the conclusion
of bending force application was stopped before the break-
ing failure point of each specimen. Force and displacement
as well as elastic stiffness (N/mm) were recorded. Unstable
mandibular specimens were excluded from mechanical test-
ing. After mechanical analysis, specimens were immersed in
10% formaldehyde for subsequent histological preparation
and analysis.
Histological analysis
All histological processing and specimen analyses were per-
formed at the Department of Biomaterials of the Radboud
University Nijmegen Medical Centre, The Netherlands.
The specimens were reduced in size, dehydrated in a
graded series of ethanol, embedded in methyl methacrylate
resin, and polymerized. The tissue blocks were mounted in
a modiﬁed inner circular saw microtome (LeicaV
R
RM 2165,
Wetzlar, Germany), and 10-lm-thick sections were prepared.
Serial bucco-lingual cross-sections were stained with meth-
ylene blue and basic fuchsin for histology and histomorpho-
metric analysis. At least seven bucco-lingual histological
cross-sections were prepared from the reconstructed mandi-
ble from each specimen, that is, one at the midline of the
device’s body, three at the junction between the device body




, Rijswijk, The Netherlands)
was used for histological evaluation, which included a gen-
eral description of the tissue surrounding the implant’s
body, the junction of the body and the scaffold’s stem, and
the stem areas.
Histomorphometric analysis was performed by one
observer (CN). A modiﬁed hard-tissue histologic grading
scale31 (Table I) was used to quantify the histological ﬁnd-
ings. The score of each sample was calculated. Total bone
contact (TBC) (%) and bone volume (BV) (%) were meas-
ured for at least three sections of the stem, junction, and
mid-scaffold.
Total bone contact (TBC) (%) at the stem was quantiﬁed
by microscopy at 53 and 103 magniﬁcation (ZeissV
R
com-
puter program). TBC (%) was calculated with the Image-
ProV
R
5.0 system (Media Cybernetics, Silver Spring, MD). TBC
(%) was calculated according to the formula
TBC %ð Þ 5 Total length of bone interface
Total length of stem surface
3100:
The mean bone volumes (%) were calculated 2 mm
from the stem surface (Figure 6). Bone volumes were calcu-
lated with the QWin computer program (Q-win;LeicaV
R
, Wet-
zlar, Germany) using the average value of three parallel
slices and according to the formula
Bone volume %ð Þ
5
Total bone volume ð2 area of tooth or plate=screwÞ
Calculated area 2 mm from the stem surface
3100:
Statistical analysis
Data from the mechanical tests were described by stiffness
values.
Data on bone regeneration from the micro-CT study and
data on histological measurements were statistically analyzed
with SAS 9.2 statistical software (SAS Institute, Cary, NC).
Measurements were evaluated by analysis of variance
(ANOVA) with a pair-wise comparison post-test to identify
the groups that differed from each other. This was done with-
out correction for Type I error rate across the pair-wise tests.
A p value < 0.10 was considered statistically signiﬁcant.
RESULTS
Gross view and clinical ﬁndings
Although all 24 animals survived the experimental period
and maintained their body weight well, at retrieval only 14
specimens were found to be useful for further assessment
(PCL [control] [n 5 3], PCL-BMP [n 5 6], and PCL-CELL [n
5 5]). The rest of the animals had to be excluded due to
loosen plates and screw, clinical mobility, and wound infec-
tion at the reconstruction sites (Figure 7).
Serial radiographic examinations and gross examination
showed incomplete union between bone segments in all
groups at 6 months after surgery. Radiographic bone forma-
tion was found to be higher in the PCL-BMP than in the
PCL-CELL and PCL (control) groups, and regenerated bone
was also found outside the scaffold, especially in the area
adjacent to the lingual periosteum. The ﬁxation plates and
screws appeared to be loose in some specimens (Figure 8).
Micro-CT analysis
Micro-CT revealed that bone regeneration in the various
PCL scaffold groups never resulted in complete repair of the
continuity defects at 6 months. Deformation of the scaffold,
that is, bending or fracture between the stem and the body
of the scaffold, was found in two specimens (PCL-control
and PCL-CELL). The lingual side of the mandibular defect
showed homogeneous bone regeneration.
Calculated mean bone volume (mm3) at the reconstruc-
tion side (area between mandibular segments) was found,
for PCL-control, PCL-CELL, and PCL-BMP, to be 210.07 6
112.37, 566.66 6 371.30, and 481.98 6 281.60 mm3,
respectively. However, bone formation presented mainly at
the lingual side of the defect, and some regenerated bone
was separated from the scaffold. Further evaluation of new
bone formation inside the scaffold structures revealed a
high level of bone formation in the PCL-BMP group com-
pared with the other groups (Figure 10). Mean bone volume
inside the scaffold for PCL-control, PCL-CELL, and PCL-BMP
was 27.98 6 34.64, 9.21 6 7.42, and 153.45 6 171.42
mm3, respectively.
The mean tissue mineral content (TMC) for PCL-control,
PCL-CELL, and PCL-BMP was 14.15 6 17.34, 4.87 6 4.08,
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and 82.96 6 91.33 mg, respectively, and the mean tissue
mineral density (TMD) for PCL-control, PCL-CELL, and PCL-
BMP was 521.48 6 25.59, 491.62 6 60.73, and 547.23 6
40.13 mg HA/mL, respectively. Nevertheless, statistical anal-
ysis demonstrated that the observed differences in bone vol-
ume (outside and inside), TMC, and TMD between and
among the various groups were not signiﬁcant (p > 0.10)
(Figures 9 and 10).
Mechanical testing
Successful mechanical testing could be undertaken only on
four specimens, that is, PCL-BMP (n 5 2) and PCL-CELL (n
5 2), while the other four specimens presented with poor
stability at the reconstruction site, which did not allow for
mechanical assessment. The stiffness values on the experi-
mental side of the mandible were 7.1 and 24.4 N/mm in
the PCL-CELL group and 193 and 61.9 N/mm in the PCL-
BMP group. The mean stiffness values on the contralateral
side of the mandible were 129.4 and 198.2 N/mm in the
PCL-CELL group and 820.9 N/mm in the PCL-BMP group.
The peak load, reported as 40.41 N, was found in one of the
two samples from the PCL-CELL group and also in one sam-
ple of the PCL-BMP group, which was found to be at 72.09
N (Figure 11).
Analysis by light microscopy
Successful histological analysis was performed on 14 speci-
mens, that is, PCL-BMP (n 5 6), PCL-CELL (n 5 5), and
FIGURE 5. Histology slide sections (magnification 31) from three areas of the scaffold: (1) the stem of the scaffold, (2) the junction between the
stem and the body of the scaffold, (3) and a mid-scaffold section. The sections showed better bone formation inside the scaffold structure of the
PCL-BMP group, while mostly fibrous tissue was found in the PCL-CELL and PCL-control groups. The stem of the scaffold in the PCL-BMP group
was surrounded with bone, while fibrous connective tissue was again found in the other two groups. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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PCL-control (n 5 3), while the rest of the specimens were
excluded due to infection. The histological sections showed
more enhanced bone regeneration in the PCL-BMP than in
the PCL-CELL and PCL-control groups (Figure 12). The
PCL scaffolds showed minimal signs of degradation in all
groups. In detail, the PCL-BMP group showed normal-
appearing mature trabecular bone both outside and inside
of the scaffold’s porosity in two of the six specimens. The
majority of the cells detected were osteocytes and osteo-
blasts. The porosity of the PCL-CELL and the control
groups was mainly ﬁlled with soft tissue, with an abun-
dant presence of ﬁbroblasts and inﬂammatory cells. Islands
of bone were found related to the periosteum, especially
at the lingual side, outside the scaffold. At the junction of
the body and scaffold stem, bone formation starting from
the mandibular stump and progressing into the scaffold
porosity and bone was found to be present at the lower
border and lingual side of the mandible in three of the six
specimens from the PCL-BMP group, two of ﬁve specimens
from the PCL-CELL group, and one of three specimens
from the PCL-control group. Again, the amount of bone
formation in this region appeared to be higher for the
PCL-BMP group. Around the stems of the scaffolds, a thick
connective tissue layer was present between the stem sur-
face and native bone in most specimens. However, direct
bone contact at the interface was found in three specimens
of the PCL-BMP group and in one of the PCL-control
groups.
FIGURE 6. The Qwin computer program was used to calculate the percent bone volume from the area 2 mm around the stem implant surface.
The images show the method for identification of the ROI. The computer program identified: (a) the stem area, (b) the bone around the stem,
and (c) removal of other defects, that is, screw or root tip. The selected area (ROI) around the scaffold’s stem is used to calculate the percent
bone volume, as shown in (d). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
TABLE I. Hard-Tissue Histologic Grading Scale (Adapted and
Modified from Jansen et al.31
Parameter Score
Bone formation 2: Completely surrounded with bone
1: Partially surrounded with bone
0: No bone (fibrous formation)
Bone–device
interface
2: Completely interfaced with bone
1: Partially interfaced with bone




complete degradation or complete
fragmentation
2: Marked degradation—marked
cracks in implant and/or some
fragments toward edges and
outer surface
1: Limited degradation—some
minor dissolution on edges,
minor cracks in implant,
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Histomorphologic analysis
Bone formation around the device and bone–device inter-
face was analyzed in three areas (mid-scaffold, junction
between the scaffold body and stem, and mid-posterior
stem), and the grading scale used is depicted in Figures 13
and 14.
The mean total bone presentation grading score for the
“area around the devices” was 0.69 6 0.01 for the PCL-
control group, 0.63 6 0.01 for the PCL-CELL group, and
1.21 6 0.29 for the PCL-BMP group. The difference in total
bone presentation score between the PCL-BMP and PCL-
control groups, and also between the PCL-BMP and PCL-
FIGURE 7. Images of reconstructed mandibular specimens at 6 months. Several of the specimens successfully maintained their shape, mandibu-
lar contour, and an intact oral mucosa (white arrow) (a), while others presented with wound dehiscence. The scaffold and miniplates are
exposed through intraoral wounds (black arrow) (b). [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
FIGURE 8. Radiographic images of the reconstructed monkey mandibles: (a) PCL-BMP, (b) PCL-CELL, and (c) PCL-control. The mandibles main-
tained both shape and dimension. The new bone regeneration was found to be nearly complete in the PCL-BMP group. Incomplete bone union
was observed in the other two groups. Loosening of plates and screws was found in several specimens.
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CELL groups, was found to be statistically signiﬁcant (p <
0.10). There was no statistically signiﬁcant difference
between the PCL-control and PCL-CELL groups.
The mean total grading scores for the “bone–device
interface” were 0.19 6 0.29 for the PCL-control group, 0.12
6 0.15 for the PCL-CELL group, and 0.55 6 0.46 for the
PCL-BMP group. Statistical testing revealed no signiﬁcant
differences in the mean total grading scores between and
among groups.
The percentages of bone–device interface calculated
around the stem of the implant to the native bone were
2.26% 6 5.30 for the PCL-control group and 2.96% 6 5.01
for the PCL-BMP group, and there was no bone–device
interface (0%) in the PCL-CELL group. There were no statis-
tically signiﬁcant differences between the PCL-control and
PCL-BMP groups.
FIGURE 9. Micro-CT scan analysis results. (a) Bone volume at the
reconstruction site of each specimen. (b) Bone volume formation
inside the PCL scaffold in each specimen. [Color figure can be viewed
in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 10. Micro-CT scan analysis. (a) Mean bone volume at the reconstruction site of each specimen. (b) Mean bone volume inside the PCL
scaffold. There was no significant difference in mean bone volume at the reconstruction site and inside the scaffold among the three groups (p
> 0.010).
FIGURE 11. Stiffness values of three-point bending in monkey mandi-
bles. Stiffness value in the PCL-CELL is 7.1 and 24.4 N/mm while load-
ing force was applied to the experimental side and 129.4 and 198.2 N/
mm with force applied to the contralateral side. Stiffness value in
PCL-BMP is 193 and 61.9 N/mm while loading force was applied to
the experimental side and 820.9 N/mm with force applied at the con-
tralateral side. Mechanical testing could not be performed on any of
the PCL-control specimens, due to weakness at the reconstruction
site. [Color figure can be viewed in the online issue, which is available
at wileyonlinelibrary.com.]
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The mean scores for scaffold degradation were 0 for the
PCL-control group, 0 for the PCL-CELL group, and 0.78 6
0.43 for PCL-BMP groups [Figure 14(d)].
The results of the bone contact and bone volume per-
centages, as determined with image analysis software, are
depicted in Figure 15. The differences in mean percent bone
volume (%), calculated in the area of 2 mm around the
stem implant surface, were 27.67% 6 0.19 for the PCL-
control group, 32.65% 6 15.58 for the PCL-CELL group,
and 56.33% 6 6.98 for the PCL-BMP groups. The mean per-
cent bone volume between the PCL-BMP and PCL-CELL
groups and between the PCL-BMP and PCL-control groups
was found to be statistically signiﬁcant (p < 0.10) among
the groups. There was no statistically signiﬁcant difference
between the PCL-control and PCL-CELL groups.
DISCUSSION
This study is the ﬁrst attempt to reconstruct a mandibular
body segmental defect using the endoprosthesis-designed
PCL scaffold combined with either rhBMP-2 or autologous
bone marrow cells in a non-human primate model. The con-
tinuity defect of segmental resection in the study was simi-
lar to those resulting from ablative surgery, for example,
trauma, tumors, or osteomyelitis in the oral and maxillofa-
cial region. We proposed to compare the degrees of bone
regeneration that occurred from the PCL scaffold recon-
struction resulting from the addition of either rhBMP-2 or
autologous bone marrow cells.
M. fascicularis monkeys were selected in this study due
to their anatomic and biological mandibular similarity to
humans.3,32 The 6-month follow-up period was considered
FIGURE 12. Histology slide sections of scaffold porosity at the mid-scaffold region: PCL-BMP (a) to (c), PCL-CELL (d) to (f), and PCL-control (g) to
(i). Bone formation was found in PCL-BMP scaffold pores, while connective tissue was observed in the other two groups. Good bone-scaffold
contact with areas of scaffold degradation was seen along the edge in the PCL-BMP group. CN 5 connective tissue, *inflammatory cells, and
arrows 5 bone-scaffold contact areas. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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suitable based on results from previous studies on the simi-
lar healing of a defect site in the same model evaluating
bone bridge formation in a mandibular continuity defect by
a tissue-engineering technique,16,33–36 including reconstruc-
tion with a titanium alloy modular endoprosthesis.5
Although the non-primate human model is closed to clinical
study, the immobilized jaw movement by the inter-maxillary
ﬁxation (IMF) cannot be performed, unlike in humans.
Therefore, the identiﬁcation of an alternative method for
early stabilization of the reconstruction site was crucial.
Although the addition of internal ﬁxation with two mini-
plates and screws was used to maintain the mandibular
integrity of bone segments in the study, unfortunately, the
results demonstrated insufﬁcient load-bearing capacity in
most of the animals, and, subsequently, infection was found
in many specimens.
The immediate loading force and the intra-oral surgical
approach appeared to be related to wound dehiscence and
disrupted the achievement of bone union. Wound dehis-
cence was experienced by the animals as an “uncomfortable
feeling” and resulted in additional disturbance of the
wounds by the monkeys with their ﬁngers. Wound dehis-
cence as well as dislodgement of the mini-plates and screws
led to a limited number of appropriate specimens for fur-
ther evaluation. Therefore, the data should be interpreted
with caution.
There was incomplete bone union in all study groups;
therefore, we rejected the hypothesis that an osteoinductive
scaffold loaded with rhBMP-2 or bone marrow cells could
achieve bone union and overlying soft-tissue healing with
sufﬁcient load-bearing capacity within 6 months. However,
the ﬁndings showed that the amount of bone in-growth was
higher in the PCL-BMP-2 group compared with that in the
PCL-CELL and PCL-control groups. The micro-CT imaging in
one specimen from the PCL-BMP group showed a nearly
complete bone union with bone in-growth. The mechanical
test showed that the mandible reconstructed with PCL-BMP
had a higher load-bearing capacity compared with that of
the other groups. Nonetheless, with the limitation that the
study was discontinued at 6 months, it might be possible
that bone formation and bone union in the PCL-BMP group
may or may not continue if a follow-up period was set at
more than 6 months. However, based on the current ﬁnd-
ings, the PLC-BMP-2 reconstruction has potential for bone
regeneration in mandibular continuity defects.
Basic bone bioengineering can be accomplished relative
to many factors, including bone scaffold, growth factors, bio-
logic cells, and surrounding vascular blood supply, especially
in large reconstruction sites.37,38 The ideal biomaterial prop-
erties for bone scaffolds were identiﬁed as biocompatibility,
a capacity for facilitating revascularization, osteoinductive,
and osteoconductive properties, and a structure providing a
framework for new bone development while allowing for
the incorporation of osteogenic factors.38 Furthermore, the
material should be easily shaped into complex components,
as well as being malleable, sterilizable, storable, and afford-
able. The material stiffness should offer an initial primary
stability for the reconstruction site with subsequent gradual
degradation corresponding with newly deposited bone in-
growth, to maintain the proper load-bearing capacity. The
candidate scaffold materials that closely fulﬁll such require-
ments are bioresorbable aliphatic polyesters, such as poly-
glycolide, polylactide, PCL, and their copolymers.
PCL is the FDA-approved material used in multiple med-
ical device formulations.12 It already has a signiﬁcant his-
tory of regulatory approval, with minimal inﬂammatory and
immunological responses,39,40 and has been used in clinical
applications highly biocompatible with osteoblasts. The
thermoplastic quality of PCL allows it to be processed in
three dimensions with the desired geometry, and for con-
trolled porosity with interconnectivity by modern computer-
based solid free-form fabrication technology. In this study,
the scaffold was designed to follow the anatomy of a mon-
key mandible based on the computed scan (CT) data. It was
FIGURE 13. Bone present around the scaffolds: (a) mid-body, (b) junc-
tion, and (c) scaffold stem. The score scale: 0, no bone (fibrous forma-
tion); 1, partially surrounded with bone; and 2, completely
surrounded with bone. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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comprised of a body segment with two modular endopros-
thesis stems inserted into the prepared cancellous cavity of
a native mandible. The PCL scaffold was intended to main-
tain the stability of the mandible and to support the ana-
tomical regeneration of the bone defect.
Among growth factors for the enhancement of bone
regeneration, BMPs have been reported to be successful in
bone reconstruction. The selected carriers reported in the
literature were collagen sponges,16,35,41,42 poly-D,L-lactic-co-
glycolic acid-coated gelatin sponges (PGS),43 poly-D,L-lactic
coglycolic acid (PLGA)-coated gelatin sponges (PGS),44 poly-
glycolic co-lactic acid (PGLA),45 and autologous bone graft
of freeze-dried bone.46 Among these materials, the collagen
type-I sponge was found to be the most frequently used in
preclinical and clinical studies in segmental mandibular
reconstruction with promising results. However, the collagen
sponge lacks sufﬁcient structural integrity to maintain the
defect space compared with a bone graft and also lacks
loading capacity.18 Therefore, there is great interest in the
search for other bone scaffold carriers better suited to bone
defect repair.18 PCL is a candidate material. Although it has
non-osteoinductive properties, an engineered CHA surface
coating on PCL has been proven to allow protein molecules
such as rhBMP-2 to attach and be released in a controlled
manner,12,13 as was used in this study.
The porosity of the scaffold functions as a repository for
housing bone marrow mesenchymal cells to be transported
to the reconstruction site. The autologous bone marrow
cells used in this study were aspirated from the autologous
trochanter bone, as we noted that the monkey’s iliac bone
size was small. The autologous bone marrow cells were
processed and seeded into the scaffolds for reconstruction
without the in vitro incubation process, so that the bone
reconstruction process could be completed within the same
operation. This approach was found to compromise the
function and morphogenic ability of the bone marrow cells
possibly related to poor cell viability after implantation. The
bone regeneration results in the PCL-CELL group were com-
plicated by wound infection without bone in-growth. The
lack of bone formation in the center of the scaffold possibly
resulted from insufﬁcient blood supply to the inner side of
the scaffold structure, required to maintain cell survival.
The results therefore did not differ from those of the control
group. The conclusions resulting from the use of a PCL
FIGURE 14. Scoring of bone-scaffold interface at three areas: (a) mid-body, (b) junction, and (c) scaffold stem. 0, No bone (fibrous formation); 1,
partial interface with bone; and 2, complete interface with bone. Percentage of bone interface around the stem of the scaffold and scoring of
scaffold degradation are shown in (d). Score scale for scaffold degradation is described as: 0, no degradation; 1, limited degradation; 2, severe
degradation; and 3, bone has completely disappeared. [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
FIGURE 15. Percentage bone volume (%) calculated from the ROI
(area 2 mm around the scaffold stems). [Color figure can be viewed
in the online issue, which is available at wileyonlinelibrary.com.]
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scaffold combined with autologous bone marrow cells
yielded insufﬁcient supporting data. The methodology on
cellular approaches to bone regeneration requires further
study.
The acknowledged slow degradation phenomenon of
PCL, which depends on random hydrolytic chain scission of
the ester linkages, may vary from months to years.47 Poly-
mer degradation can be characterized as a decrease in the
rate of chain scission and the onset of implant weight loss,
fragmentation, and intracellular degradation.48 This slow
degradation could even hamper bone in-growth. The PCL
scaffold degradation in this study was limited, and the
remaining structure was still present at the end of the
study. However, the actual amount of PCL degradation, for
example, molecular weight loss, was not evaluated in this
study.
Further studies will be needed to determine the optimal
methodology and parameters prior to clinical use. In future
studies, additional steps can be taken to increase the stabil-
ity of the endoprosthesis. A surgical approach to mandibular
reconstruction should preferably be performed extra-orally
to reduce wound dehiscence and infection rates. PCL can be
the material of choice; however, after insertion into the
mandible, the modular components of the scaffold can be
heat-welded together to increase the rigidity of the prosthe-
sis. Importantly, sufﬁcient rigid plate(s) ﬁxation should be
used to improve the primary stability of the reconstructed
site, especially in the initial stage of reconstruction. The pro-
tocol for bone marrow cell preparation and seeding requires
revision if promising results are to be achieved.
CONCLUSION
In conclusion, the results of our study did not conﬁrm the
original hypothesis. Based on the data obtained, no satisfac-
tory bone formation occurred between the mandibular seg-
ments at 6 months after surgery in any of the three groups.
There was a high rate of infection and dislodgement of the
ﬁxation plates and the PCL endoprosthesis scaffold. Never-
theless, the BMP-2-loaded PCL scaffolds were found to per-
form better in terms of bone formation and mechanical
testing than empty PCL scaffolds and scaffolds loaded with
autogenous BMSCs. This suggests that this might be a feasi-
ble approach for further study in reconstructing segmental
mandibular defects.
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